MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential
Pancreatic cancer is one of the most aggressive malignancies, accounting for more than 45,750 deaths annually in the U.S. alone. The aggressive nature and late diagnosis of pancreatic cancer, coupled with the limitations of existing chemotherapy, present the pressing need for the development of nove...
Main Authors: | Manmeet Rawat, Kavita Kadian, Yash Gupta, Anand Kumar, Patrick S.G. Chain, Olga Kovbasnjuk, Suneel Kumar, Gulshan Parasher |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/10/10/752 |
Similar Items
-
MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
by: Afra Z. Daoud, et al.
Published: (2019-11-01) -
Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy
by: Marta Passadouro, et al.
Published: (2016-05-01) -
Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01) -
Targeting MicroRNA Function in Acute Pancreatitis
by: Hong Xiang, et al.
Published: (2017-09-01) -
A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma
by: Yu Y, et al.
Published: (2018-06-01)